Form 4: Pyxis Oncology Insider Buys Shares
Insider Transaction (Form 4)
GordonMD Global Investments LP and 3 others reported changes in beneficial ownership of Pyxis Oncology, Inc. common stock on October 1, 2026.
Summary
- Open-market purchase: acquired 5,517,000 Common Stock, par value $0.001 per share ("Common Stock") on October 1, 2026; holds 15,541,909 after (Indirect).
- Open-market purchase: acquired 7,546,766 Common Stock Purchase Warrant on October 1, 2026; holds 7,546,766 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $0, committing personal capital to the stock.
Insider Transactions
GordonMD Global Investments LP — 10% owner
GordonMD Long Biased Master Fund LP — 10% owner
GordonMD Long Biased GP LLC — 10% owner
Craig D Gordon — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market purchase | Common Stock, par value $0.001 per share ("Common Stock") | 5,517,000 | — | — | 15,541,909 |
| 2026-10-01 | Open-market purchase | Common Stock Purchase Warrant | 7,546,766 | — | — | 7,546,766 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market purchase (5,517,000 shares) |
| 2026-10-01 | Open-market purchase (7,546,766 shares) |
Keywords
insider transaction, Form 4, PYXS, Pyxis Oncology, Inc., bullish, GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, GordonMD Long Biased GP LLC, Craig D Gordon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.